LVADs have been life-savers for decades and, for a number of years, hospitals had a choice of two devices - the HeartWare ...

Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the late 1980s ...

Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable left ventricular assist device for patients with advanced HF. Perspective from Frank Smart, ...

Let's say you're one of the nearly 7 million Americans with heart failure. Your heart’s ability to pump blood is impaired. Despite being on all the right medicines, at doses as high as you can ...

Las Vegas, NV - The preliminary results from a large prospective study of cardiac function during left ventricular assist device (LVAD) support have found that left ventricular ejection fraction (LVEF ...

Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rglp75/global_left) has announced the addition of the "Global Left ...

Heart failure is one of the most pressing health challenges of our time, affecting over 64 million people worldwide and driving significant mortality, morbidity, and healthcare costs. As donor heart ...

DANVILLE, Pa. — It's called a Left Ventricular Assist Device or LVAD for short. To some, it may look like a random piece of medical equipment, but to Susanne Brown of Williamsport, it's what saved her ...

TikToker Sofia Hart documents life with an LVAD — a device that keeps her heart pumping — while she awaits a heart transplant When Sofia Hart wakes up in the morning, she brushes her teeth and makes ...

When retired Marine Corps officer Steve Snowden faced the biggest battle of his life—heart failure at age 81—he turned to the ...

The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.